Innovative and accredited continuing medical education for today’s practicing clinicians.

CME Institute is trusted by physicians across medical specialties for premium continuing education that yields the highest educational outcomes. These ACCME-accredited activities make the latest research, novel therapies, and clinical best practices accessible and approachable for physician, NP, PA, and PharmD learners.

Expert-led insights to improve patient outcomes
Multi-modal courses to suit all learning styles
Timely topics for relevant application to practice
Razor-focused approach to innovation that includes documentary-style video and micro-learning Tweetorials
A commitment to collective mindfulness

Recent courses

Video Self-study / Enduring Parkinson's Disease Psychosis: Review of Neuropsychiatric Complications Parkinson Disease An average of 35% of patients diagnosed with Parkinson’s disease experience Parkinson’s psychosis. Recognition and diagnosis of this nonmotor manifestation is critical in choosing the best treatment strategy and managing these symptoms. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Tweetorial Self-study / Enduring Tweetorial: A Rationale for Treating CKD with Combination Therapy Renal Disease Cardiology Clinicians have a number of therapeutic agents to choose from when treating T2D at risk of CKD. However, it's important to know how to sequence these therapies in real-world practice. 0.25 AMA PRA Category 1 Credit™ 0.25 Participation	Video Self-study / Enduring Episode 1: Why the Duration Until Onset of Antidepressant Matters Depression Major Depressive Disorder Women’s Mental Health Pharmacology for MDD is limited by low efficacy, delayed response, and side effects. Research on the pathophysiology of the disease that includes the glutamatergic system and GABA signaling is ushering in a new era for rapidly acting antidepressants. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation
Video Self-study / Enduring Episode 2: Update on Rapid-Onset Therapies for Major Depressive Disorder Depression Major Depressive Disorder Women’s Mental Health The new fast-acting antidepressants esketamine, an NMDA receptor antagonist, and positive allosteric modulators of GABAergic neurotransmission brexanolone and zuranolone have created an important and exciting paradigm shift in the treatment of depression. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Tweetorial Self-study / Enduring Tweetorial: Improving Clinician Awareness of #RettSyndrome and Optimizing Management of Care Across the Patient Lifespan Rett Syndrome Because of the multiple comorbidities and symptoms associated with Rett syndrome, clinicians are advised to implement a multidisciplinary approach to disease management with an eye toward new and emerging therapies on the horizon. 0.25 AMA PRA Category 1 Credit™ 0.25 Participation	Video Self-study / Enduring Improving Clinician Awareness of Rett Syndrome and Optimizing Management of Care Across the Patient Lifespan Rett Syndrome Child and Adolescent Psychiatry Movement Disorders Neurology Because of the multiple comorbidities associated with Rett syndrome, clinicians are advised to incorporate clinical guidelines that suggest implementing therapeutics with a multidisciplinary approach and with an eye toward new and emerging therapies. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation
Tweetorial Self-study / Enduring Tweetorial: Subtle Symptoms of Tardive Dyskinesia Have a Huge Impact on Early Recognition and Intervention Tardive Dyskinesia In this Tweetorial learn the causes, signs and symptoms, assessments tools, and treatments for the medication-induced movement disorder tardive dyskinesia. 0.25 AMA PRA Category 1 Credit™ 0.25 Participation	Video Self-study / Enduring An Individualized Approach to PAH Therapy Based on Clinical Data, Goal-Directed Therapy, and Risk Stratification  Cardiology Comorbidity Education Integrated Care Medical Conditions Pulmonary Disease Pulmonary arterial hypertension requires risk stratification to develop goal-directed treatment plans, including combination therapy targeting multiple pathways. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation	Journal Self-study / Enduring Recent Advances in Screening for Mild Cognitive Impairment and Alzheimer Disease Alzheimer Disease Cognition Dementia Geriatric Psychiatry Neurology Among the most transformative Alzheimer Disease discoveries is the existence of biomarkers which can manifest decades before onset of disease-related dementia. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation
Journal Self-study / Enduring The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease Alzheimer Disease Cognition Dementia Geriatric Psychiatry Neurology Navigating the associated differential diagnosis in AD is essential as various causes of cognitive impairment require different treatment strategies. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Video Self-study / Enduring Translating Clinical Trial Data into Real-World Practice: Examining CKD Screening and Three Patient Case Profiles Renal Disease Adherence Cardiology Comorbidity Diagnostic Tools Education Medical Conditions Primary Care Side Effects Weight Regular screening of UACR and adding finerenone to SGLT2 inhibitors can greatly impact T2D at risk for CKD. Join faculty as they discuss three patient cases. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation	Journal Self-study / Enduring An Update on the Future of Wilson Disease Management Wilson Disease Genetics Due to Wilson disease myriad manifestations, its rarity, and its range of symptoms, differential diagnosis may be challenging, leading to delays in treatment. This Neuroscience Commentary reviews diagnostic acumen and the latest updates in the field. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation

Pages

My Courses

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.